Table 2.
Expression of HIF-2α and VEGF mRNA in CSCC and clinicopathological parameters.
| Case number | HIF-2α mRNA level | VEGF mRNA level | |
|---|---|---|---|
| Age | |||
| ≤40 | 10 | 1.337 ± 0.88a | 4.276 ± 2.53d |
| >40 | 54 | 1.348 ± 0.85 | 4.532 ± 2.84 |
| FIGO stage | |||
| Stage I | 30 | 1.242 ± 0.78b | 3.284 ± 1.84e |
| Stage II | 24 | 1.847 ± 0.93 | 5.352 ± 2.37 |
| Stages III-IV | 10 | 3.023 ± 1.13 | 7.125 ± 2.98 |
| Lymphatic metastasis | |||
| No | 50 | 1.215 ± 0.84c | 3.638 ± 1.76f |
| Yes | 14 | 2.803 ± 1.12 | 6.421 ± 2.73 |
aCompared with >40 group, t = 0.05, p = 0.960. bCompared with other FIGO stages, F = 15.04, p < 0.01. cCompared with yes group, t = 3.169, p < 0.01. dCompared with >40 group, t = 0.367, p = 0.715. eCompared with other FIGO stages, F = 12.81, p < 0.01. fCompared with yes group, t = 3.615, p < 0.01.